Oxygen Concentrator — Markets Reach $3.2 Billion By 2018
LEXINGTON, Massachusetts (February 7, 2012) – WinterGreen Research announces that it has a new study on Oxygen Concentrator Market Shares and Forecasts, Worldwide, 2012-2018. The 2012 study has 524 pages, 191 tables and figures.
Reimbursement drives oxygen concentrator markets. People pay for medical insurance and medical insurance pays for oxygen concentrators. The Oxygen Concentrator market is moving inexorably toward portable devices that are more supportive of a lifestyle than the stationary devices.
The TCO is considerably lower with the portable Oxygen Concentrators because the need for deliveries of bottle oxygen is eliminated. The portable devices seem much preferable to the stationary devices that support refilling of oxygen containers. The refilling process is onerous.
There has been a quantum improvement in the oxygen concentrator technology. The huge jump in technology started with the introduction of AirSep’s LifeStyle, which was the first less-than-10-pound battery-operated concentrator that could be worn. AirSep has re-engineered the unit down to a 2 pound device.
This portable oxygen concentrator technology has been instantiated many times over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator which represents a technological breakthrough. The Inogen One is a complete departure from current mainstream technologies. It represents a shift away from standard large, bulky, stationary concentrator systems and inefficient and impractical portable devices.
As the old style distribution network disappears, with expensive truck rolls, it is being replaced with a homecare services model for making oxygen concentrators available. Inogen in the US, and Teijin In Japan illustrate vendors positioning to leverage this new sales model.
Homecare services address a situation where market transformation presents a new opportunity for vendors of PSA oxygen equipment. Economies of scale and a new distribution modality leveraging homecare services are set to change the medical oxygen industry.
Innovative products drive a significant homecare service business. Inogen is a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy. Inogen products tailored to oxygen therapy users provide the base for a services business catering to users in their homes.
Inogen is a technology leader in the oxygen concentrator business. It combines the offering of a portable oxygen concentrator in demand by patients with a home care services organization. It has contracts with veterans all over the US. Inogen has expanded its home oxygen therapy service area to include the state of Florida.
Inogen is an innovator in oxygen therapy products and services. Inogen has restored freedom and independence to thousands of oxygen therapy users throughout the US. It is able to offer access to the residents of Florida. The State of Florida has the largest percentage of senior citizens of any U.S. state as retirees are drawn to the pleasant climate that allows them to remain active. To complement their active lifestyle, oxygen therapy users need an oxygen solution that works.
In Japan the Teijin Group is a leader in the field of oxygen concentrators for home oxygen therapy (HOT). Home oxygen therapy is used by patients with chronic respiratory distress such as pulmonary emphysema. A team of various specialist staff provides a 24-hour, 365-day nationwide patient support network with over 90 bases throughout the country, enabling patients to stay in the comfort of their own homes without concern.
The Teijin Group provides unique and revolutionary solutions. These are in the fields of pharmaceuticals and home health care. With a focus on three key therapeutic areas: a bone and joint, respiratory, and cardiovascular and metabolic disease, Teijin is an example of a well-positioned company.
The government provides people over age 65 with medical insurance in the US. New initiatives provide for universal healthcare coverage. In many parts of the developed world, there is complete medical coverage provided by the government, though working people tend to supplement government coverage with medical insurance.
As the population ages, people are more frail and need assistance for supplemental oxygen if they have respiratory disease, COPD or emphysema. Technology is evolving to give people with disabilities more mobility as batteries weigh less and devices are smaller. Mobility depends on an oxygen concentrator that is fit to purpose.
Markets are poised to create the ability for people to get more exercise and impact the healthcare delivery industry by encouraging mobility of people who were previously bed ridden. Oxygen concentrators impact care delivery, permitting the patient to control mobility for the rehabilitation efforts.
Invacare is an industry leader in the market for oxygen concentrators and home medical products. It is a quality company. Its leadership position is bolstered by the ability to offer quality products and an enviable distribution network. Invacare is very happy to take care of its distribution network, not competing with it by selling directly. Invacare is very good about supporting the dealers in every way, including helping with financing.
Oxygen concentrator markets at $521 million in 2011 are expected to reach $3.2 billion by 2018. Growth is expected to be worldwide and a result of vendor achievement of marked improvements in the technology that provide patients with better oxygen delivery, permitting patients to live longer.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial.